Potential Drug-Drug Interactions with Antimicrobials in Hospitalized Patients: A Multicenter Point-Prevalence Study

Ferit Kuscu1, Aslihan Ulu1, Ayse S Inal1

  • 1Department of Infectious Diseases and Clinical Microbiology, Cukurova University Faculty of Medicine, Adana, Turkey.

Insights

Hospitalized patients frequently experience drug interactions with antimicrobials. Specific antibiotics like quinolones and macrolides pose a high risk, necessitating physician caution during prescription.

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Drug Safety

Background:

  • Improper antimicrobial use leads to adverse drug events and increased healthcare costs.
  • Drug-drug interactions (DDIs) are a significant concern in hospitalized patients.

Purpose of the Study:

  • To determine the frequency of potential drug-drug interactions involving antimicrobial agents in hospitalized patients.
  • To identify specific antimicrobial classes associated with a higher risk of interactions.

Main Methods:

  • A cross-sectional study conducted in five Turkish hospitals.
  • Inclusion criteria: patients aged 18+ receiving at least one antimicrobial and one other drug.
  • Interactions assessed using the Micromedex® online drug reference system and classified by severity.

Main Results:

  • Antimicrobial-related drug interactions constituted 26.4% of all identified interactions.
  • Quinolones, triazoles, metronidazole, linezolid, and clarithromycin were involved in 92.1% of interactions despite representing only 25.7% of prescribed antimicrobials.
  • Independent risk factors for DDIs included the number of antimicrobials, number of total drugs, and hospitalization at a university hospital.

Conclusions:

  • Physicians must exercise increased caution when prescribing antimicrobials due to the significant risk of drug interactions.
  • Specific focus is needed on high-risk antimicrobial agents such as quinolones, linezolid, azoles, metronidazole, and macrolides to mitigate potential adverse events.

Related Concept Videos

Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
454
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.5K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
257
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
611
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
278
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269